Graniforce MD Tablet

About

Graniforce MD Tablet contains Granisetron, a highly selective 5-HT3 receptor antagonist, designed to combat nausea and vomiting. Its mechanism involves blocking serotonin, a key neurotransmitter that triggers emetic responses in the brain's chemoreceptor trigger zone and the gastrointestinal tract's vagal afferents. This targeted action makes it particularly effective in preventing and treating emesis induced by chemotherapy, radiation therapy, and surgical procedures.

The "MD" (Mouth Dissolving) formulation offers a significant advantage for patients who have difficulty swallowing traditional tablets or who are experiencing acute nausea, as it dissolves rapidly on the tongue without the need for water. This ensures quick absorption and prompt relief, enhancing patient compliance and comfort during challenging medical treatments. Granisetron's efficacy and favorable tolerability profile make it a cornerstone in antiemetic therapy.

Uses

• Prevention of chemotherapy-induced nausea and vomiting.
• Management of radiation-induced nausea and vomiting.
• Prevention of post-operative nausea and vomiting.
• Relief from severe nausea and vomiting in various clinical settings.

Directions For Use

Place the tablet on your tongue and allow it to dissolve completely before swallowing. Do not chew or crush the tablet.

Benefits

• Rapid dissolution and absorption for quick action.
• Effective in preventing and treating emesis.
• Convenient mouth-dissolving formulation.
• Reduces discomfort associated with nausea and vomiting.
• Improves patient adherence, especially in acute episodes.
• Well-tolerated with a low incidence of severe side effects.

Side Effects

• Headache
• Constipation
• Diarrhea
• Dizziness
• Fatigue
• Insomnia
• Abdominal pain
• Fever
• Anxiety
• Rash
• Bradycardia
• Hypersensitivity reactions

Safety Measures

• Alcohol - Alcohol may intensify central nervous system side effects like dizziness and could irritate the stomach, potentially worsening nausea. Avoid concurrent use.
• Pregnancy - Consult your doctor before using this medication during pregnancy. It should only be used if the potential benefits justify the potential risks to the fetus.
• Breastfeeding - It is not known if Granisetron is excreted in human milk. A decision should be made whether to discontinue nursing or to discontinue the drug.
• Liver - Patients with severe hepatic impairment should use Granisetron with caution. Dose adjustments may be necessary as determined by a physician.
• Kidney - No specific dose adjustment is generally required for patients with renal impairment, but clinical monitoring is recommended in severe cases.
• Lung - Granisetron is generally considered safe for patients with pre-existing lung conditions; no specific pulmonary precautions are typically needed.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.